Trial Profile
A Phase 3, Randomized, Double-Blind, Saline Placebo- and Active-Controlled, Multicenter Study to Evaluate the Analgesic Efficacy and Safety of Intra-operative Administration of PRF-110 Following Unilateral Bunionectomy
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 20 Dec 2023
Price :
$35
*
At a glance
- Drugs Ropivacaine (Primary)
- Indications Postoperative pain
- Focus Registrational; Therapeutic Use
- Sponsors PainReform
- 20 Mar 2023 New source identified and integrated ClinicalTrials.gov: (US National Institutes of Health: NCT05773846).
- 06 Mar 2023 Status changed from planning to recruiting.
- 24 Jul 2018 New trial record